The field of spatial biology is advancing rapidly and has already contributed to novel insights in neuroscience, infectious disease, and autoimmune disorders by opening up the study of disease pathology. Immuno-oncology on the other hand has been proving grounds for spatial biology tools, which are poised to transform clinical research in several key ways.
Although it’s evident that spatial biology is supporting as well transforming drug discovery, tackling the spatial heterogeneity of tissue microenvironments from different angles, computational analysis of spatially resolved transcriptomic data and meeting the cutting-edge demands of biomedical research in general has been challenging. Furthermore, there is a significant need for collaboration between industry and academia for facilitating their application in pre-clinical and clinical settings.
To facilitate the latter point, discuss challenges and upcoming strategies the Spatial Biology Webinar will serve as a platform to brainstorm about the latest spatial technologies and the discoveries they enable across multiple biomedical disciplines with an emphasis on immuno-oncology.
Expert Speaker Line-Up Includes:
Bernie Marcus Early-Career Professor
Wallace H. Coulter Department of Biomedical Engineering
Georgia Institute of Technology & Emory University
Director of the Quantitative Sciences Division, co-Director Convergence Institute/ Single-Cell Consortium, Associate Cancer Center Director of Quantitative Sciences
Associate Professor of Oncology, Biomedical Engineering, and Applied Mathematics and Statistics
Johns Hopkins University
Professor (primary), Department of Biomedical Engineering, Yale University
Professor (secondary), Department of Pathology, Yale School of Medicine
Yale Cancer Center (YCC), Yale Stem Cell Center (YSCC), and the Human & Translational Immunology Program (HTI)
Data Scientist – AIDA (Artificial Intelligence and Deep Analytics R&D department)
Sanofi
Group leader in the Molecular Medicine Partnership Unit, ERC Investigator, EMBL
Postdoctoral Fellow, Bayraktar Group, Cellular Genetics, Wellcome Sanger Institute, UK
Scientific Marketing Specialist, Lunaphore
Junior Application Development Sustaining Engineer, Lunaphore
Session Technology Partners:
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com
